EP2439273
Manna einstofna mótefni gegn stýrðum dauða 1 (PD-1) og aðferðir til að meðhöndla krabbamein með því að nota mótefni gegn PD-1 ein og sér eða ásamt annarri ónæmismeðferð
:
EP Einkaleyfi fallið úr gildi:
2.5.2006:
27.2.2019:
11178191.0
:
23.5.2019:
15.7.2019
:
1.5.2026:
1.5.2021
:
Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
2.5.2006
27.2.2019
23.5.2019
15.7.2019
1.5.2021
:
ONO PHARMACEUTICAL CO., LTD.:
1-5, Doshomachi 2-chome Chuo-ku, 541-8526, Osaka-shi, Osaka, JP
:
E. R. Squibb & Sons, L.L.C.:
Route 206 & Province Line Road, 08540, Princeton, NJ, US
:
Srinivasan, Mohan:
Redwood City,CA, US
:
Wang, Changyu:
Redwood City,CA, US
:
Selby, Mark, J.:
Redwood City,CA, US
:
Chen, Bing:
Redwood City,CA, US
:
Cardarelli, Josephine, M.:
Redwood City,CA, US
:
Korman, Alan, J.:
Redwood City,CA, US
:
Huang, Haichun:
Redwood City,CA, US
:
G.H. Sigurgeirsson ehf.:
Borgartúni 26, 105, Reykjavík,
:
679466 P:
9.5.2005:
US
:
738434 P:
21.11.2005:
US
:
748919 P:
8.12.2005:
US
:
C12N 15/09, C07K 16/28, C12N 5/00, C12P 21/08, C12Q 1/02
: 14
: 5.4.2019
: 1.5.2020
: Árnason Faktor
: 15
: 7.4.2020
: 1.5.2021
: Árnason Faktor ehf.